EP2855448

5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    14.5.2013
  • :
    8.2.2017
  • :
    13723910.9
  • :
    13.5.2033
  • :
    5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

14.5.2013
8.2.2017
  • :
    Cancer Research Technology Ltd
  • :
    Angel Building, 407 St John Street, London, Greater London EC1V 4AD, GB
  • :
    COLLINS, Ian
  • :
    SuttonSurrey SM2 5NG, GB
  • :
    MATTHEWS, Thomas Peter
  • :
    SuttonSurrey SM2 5NG, GB
  • :
    FARIA DA FONSECA MCHARDY, Tatiana
  • :
    SuttonSurrey SM2 5NG, GB
  • :
    OSBORNE, James
  • :
    Saffron WaldenEssex CB10 1XL, GB
  • :
    LAINCHBURY, Michael
  • :
    HarlowEssex CM19 5TR, GB
  • :
    WALTON, Michael Ian
  • :
    SuttonSurrey SM2 5NG, GB
  • :
    GARRETT, Michelle Dawn
  • :
    CanterburyKent CT5 3EU, GB
  • :
    201261647200 P
  • :
    15.5.2012
  • :
    US
  • :
    GB2013051233
  • :
    14.5.2013
  • :
    C07D 401/12, A61K 31/506, A61P 35/00